Skip Navigation

JNCI Journal of the National Cancer Institute 2003 95(16):1195; doi:10.1093/jnci/95.16.1195
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 Oxford University Press

NEWS

In Brief

The first 10% of the full text of this article appears below.

Study Examines PSA Threshold for Biopsy

A new study suggests that the commonly accepted threshold for prostate-specific antigen (PSA) levels may miss a large number of prostate cancers.

Rinaa S. Punglia, M.D., of Harvard Medical School in Boston, and her colleagues used a mathematical model to correct for verification bias—a phenomenon in which men with positive PSA findings are more likely to be recommended for a prostate biopsy than men . . . [Full Text of this Article]

Study Faults Food Surveys in Risk Analyses

Antioxidant Trial Findings Hold Up, Post-Trial Follow-Up Finds


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?